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were younger age, increased BMI, female gender, and learn-
ing curve for CSF leaks; increased tumor size for complica-
tions in general; and Rathke’s cleft cysts for diabetes insipi-
dus. Mortality (incidence rate 1%) was not addressed as a 
risk factor.
Conclusion Based on current literature, of low to medium 
quality, it is not possible to comprehensively quantify risk 
factors for complications. Nevertheless, older age and 
intraventricular extension were associated with increased 
postoperative complications. Future research should aim at 
prospective data collection, reporting of outcomes, and uni-
formity of definitions. Only then a proper risk analysis can 
be performed for endoscopic pituitary surgery.
Keywords Pituitary · Endoscopic transsphenoidal 
surgery · Risk factors · CSF leak · Bleeding · Diabetes 
insipidus
Abbreviations
ACF  Anterior cranial fossa
BMI  Body mass index
CSF  Cerebrospinal fluid
DI  Diabetes insipidus
ETS  Endoscopic transsphenoidal surgery
ICA  Internal carotid artery
QUIPS  Quality in Prognostic Studies
RCC  Rathke’s cleft cyst
SIADH  Syndrome of inappropriate anti-diuretic hor-
mone (secretion)
Introduction
Over the past two and a half decades, pituitary surgery has 
undergone major technical developments, the introduction 
Abstract 
Background The ability to preoperatively predict postop-
erative complication risks is valuable for individual coun-
seling and (post)operative planning, e.g. to select low-risk 
patients eligible for short stay surgery or those with higher 
risks requiring special attention. These risks however, are 
not well established in pituitary surgery.
Methods We conducted a systematic review of associations 
between preoperative characteristics and postoperative com-
plications of endoscopic transsphenoidal surgery accord-
ing to the PRISMA guidelines. Risk of bias was assessed 
through the QUIPS tool.
Results In total 23 articles were included, containing 5491 
patients (96% pituitary adenoma). There was a wide variety 
regarding the nature and number of risk factors, definitions, 
measurement and statistics employed, and overall quality of 
mainly retrospective studies was low. Consistent significant 
associations were older age for complications in general, 
and intraventricular extension for cerebrospinal fluid (CSF) 
leaks. Associations identified in some but not all studies 
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of the endoscope perhaps being the most important one. 
Several systematic reviews show relatively better results 
in terms of gross total resection, with reduced complica-
tion rates for endoscopic surgery compared to microscopic 
surgery [1–10]. These complication rates in endoscopic 
transsphenoidal surgery (ETS) are relatively low; however, 
they can still be significant. In clinical decision-making, 
it is important to identify patients with an increased risk 
preoperatively for obvious reasons, e.g. planning and tim-
ing of the surgical intervention. Identified individual risk 
factors may be used to stimulate awareness in an attempt 
to reduce complication rates, improve patient counseling, 
and identify patients with an expected low-risk procedure, 
eligible for short stay surgery. Consultation with or even 
referral to a center of excellence is warranted in high risk 
patients to consider different surgical and alternative treat-
ment strategies, such as medication and radiotherapy. A 
considerable number of clinical studies have reported on 
risk factors for complications after ETS; however, a sys-
tematic overview of the literature is lacking. The present 
study, therefore, aimed to systematically review the litera-
ture on preoperative risk factors for complications after 
ETS for pituitary tumors.
Methods
A systematic review was conducted according to a prede-
fined protocol, which was based on the PRISMA criteria for 
systematic reviews [11] and registered in Prospero, registra-
tion number CRD42017057835. The selection of studies, 
extraction of data, and assessment of the risk of bias were 
done by two independent reviewers (D.J.L. and F.V.). Disa-
greement was resolved through discussion and consensus. 
If discussion failed to lead to a consensus, a third researcher 
would be consulted; this did not occur, however.
Search strategy
A literature search was conducted on May 15 2017, with the 
guidance of a trained clinical librarian (J.S.). The following 
databases were searched: PubMed, Embase, Web of Sci-
ence, Cochrane, CINAHL, Academic Search Premier and 
ScienceDirect. Terms included were ‘pituitary adenoma’, 
‘non-functioning adenoma’, ‘acromegaly’, ‘Cushing’s dis-
ease’, ‘prolactinoma’, ‘Craniopharyngioma’, ‘Rathke’s 
cleft cyst’, ‘complications’, ‘risk factors’ and ‘prognosis’, 
and derivatives or synonyms of these words. The complete 
search strategy can be found in online supplement 1. Refer-
ence checking of included studies was performed to screen 
for additional studies.
Inclusion of articles
Inclusion criteria were: (1) articles reporting on outcomes 
of ETS for pituitary tumors; (2) describing an association 
between ≥1 preoperative characteristics and ≥1 postop-
erative complications; (3) published in English; (4) peer-
reviewed; (5) containing original clinical data; and (6) 
including >10 adult patients (>18 years). Excluded stud-
ies were: (a) microscopic, endoscopic-assisted surgery, or 
combined microscopic and endoscopic approaches without a 
separate description of endoscopic results, (b) articles with-
out a described association, and (c) articles including >10% 
other pathologies than pituitary adenoma.
A meta-analysis appeared to be infeasible because of het-
erogeneity in (the definition of) risk factors and outcomes. In 
addition, the number of studies assessing the same associa-
tion for a complication was too small. This review focuses 
on complications that directly intricate the postoperative 
course. Perioperative CSF leaks can be managed adequately 
during surgery and were therefore not included. Other 
reviews have addressed specific complications occurring 
during surgery; e.g. internal carotid artery (ICA) injuries 
[12] or later after discharge, e.g. delayed hyponatremia [13]. 
Both studies, however, also included microscopic studies. 
The results of these studies have been used to substantiate 
our present conclusions.
Selection of studies
The selection consisted of two phases: (1) title and abstract 
screening for potentially eligible articles, and (2) full text 
screening of these articles. During both phases, the same 
inclusion and exclusion criteria were used. During phase 1, 
in case of doubt, the full text paper was retrieved. Since a 
variety of risk factors can be investigated within the same 
cohort, a decision was made not to omit overlapping cohorts.
Data extraction
Extracted study characteristics included: institution, study 
period, study design, number of patients, number of proce-
dures, percentage females, tumor type, approach, length of 
stay, and duration of follow-up. Preoperative factors were 
categorized into groups (demographics, volumetric param-
eters, pathology, surgical factors, and endocrine parameters) 
and all potential associations were categorized into compli-
cations in general, neurosurgical and endocrine complica-
tions. Risk factors were considered consistent when they 
were reported as significant in ≥2 independent studies. 
Inconsistent when ≥2 positive or negative and ≥1 neutral 
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(non-significant) associations were reported and conflict-
ing when ≥1 positive and ≥1 negative associations were 
reported.
Risk of bias
Assessment of risk of bias was done by means of the Quality 
in Prognostic Studies (QUIPS) tool [14]. The QUIPS tool is 
the standard tool used by Cochrane to review cohort stud-
ies evaluating predictive factors for diagnosis or prognosis. 
The results of this evaluation were put in a “summary of 
findings table” (Table 1). The overall risk of bias score was 
assessed according to that of Lazzerini [15]. A low risk of 
bias was given if all six domains were scored as low, or if 
not more than two moderate or unknown risks of bias were 
identified. Moderate risk of bias was given when three or 
less risk of bias domains were scored moderate, or unknown, 
in combination with no high risk of bias. Moderate was also 
given when one domain was scored as a high risk of bias in 
combination with one or less moderate or unknown risks 
of bias. A high risk of bias was given when two or more 
domains scored a high risk of bias, or four or more moderate 
or unknown risk of bias.
Results
Search
The search resulted in 2596 unique titles and abstracts. The 
screening of titles and abstracts resulted in the selection of 
472 full-text articles retrieved for the second phase of the 
selection process. Finally, 23 articles were included in the 
present systematic review (Fig. 1).
Fig. 1  Flow chart of study 
assessment Records identified through 
database searching 
(n = 3611) 
Studies after duplicates 
removed (n = 2599) 
Studies screened 
(n = 2297) Studies excluded based on title and 
abstract (n=1825) 
Full-text articles assessed for 
eligibility 
(n = 472) Full-text articles excluded (n = 449) 
Not pure endoscopic (n=88) 
Type of surgery not specified (n=100) 
>10% other pathologies (n=5) 
Pooled data (n=46) 
No original results (n=6) 
N<10 (n=12) 
Risk factors not analyzed (n=171) 
Interim report (n=1) 
Review (n=9) 
Wrong outcomes (n=5) 
Spanish article (n=3) 
Intraoperative risk factor only (n=1) 
Duplicate study (n=1) 
Pediatric population (n=1) 
Studies included  
(n = 23) 
Studies published prior to 1997  
(n = 302) 
Duplicate studies  
(n = 1012) 
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Study characteristics
The study characteristics are summarized in Table 2. There 
were 3 prospective [16–18], and 20 retrospective observa-
tional cohort studies [19–27]. Publication was between 2008 
and 2017 and included data from 5491 patients (median 125, 
IQR 78–313), of whom 2828 (52%) were female. There were 
5291 pituitary adenomas (96%), 143 craniopharyngiomas 
(2.6%) and 39 Rathke’s cleft cysts (0.7%). Seventeen stud-
ies (61%) included patients with adenomas only [16–20, 22, 
23, 27–33], five studies included a mixture of tumor types 
[24–26, 34, 35] and one study only included patients with 
craniopharyngiomas [21].
Risk of bias
The results of the scoring of the methodological quality of 
the studies are shown in Table 1.
Overall, the methodological quality was low: only one 
study had a low risk of bias (4.3%), two a moderate risk 
(8.7%) and the remaining twenty studies had a high risk of 
bias (87.0%). A high risk of bias was found twelve times for 
study confounding (median 7.5, range 0–12).
Complication rates
The incidence rates of complications described in the 
included studies are described in Table 3. The three most 
common complications were postoperative CSF leaks 
(median 4.5%, IQR 2.6–10.2%), serious bleedings (median 
1.5%, IQR 0.6–1.7%), and permanent diabetes insipidus 
(median 2.7%, IQR 1.9–4.3%).
Risk factors for complications
Complications in general
Eight studies investigated the potential risk factors for com-
plications in general [17, 19, 20, 22, 28, 30, 31, 35]. Inci-
dence rates of complications in general were often not given. 
Furthermore, various definitions were used, varying from 
solely treating specific complications to reporting all poten-
tial complications. This included, for instance, urinary tract 
infections and cardiovascular complications. Some studies 
did not report how they defined complications in general 
[19, 22].
Table 1  Summary of findings (risk of bias)
Authors Study  
participation










Ajlan 2016 Moderate Moderate Moderate Moderate High High High
Bokhari 2013 Moderate Moderate Moderate Moderate High High High
Boling 2016 Low Moderate Moderate Moderate Moderate Low High
Cavallo 2014 Moderate Moderate Moderate Moderate High High High
Cerina 2016 Moderate Moderate Low Low Low Low Low
Chabot 2015 Low Moderate Low Moderate High Moderate High
Chi 2013 Moderate Moderate Low Moderate Moderate Moderate High
Chohan 2016 Moderate Low Moderate Moderate Moderate Moderate High
Dallapiaza 2014 Moderate High Moderate Moderate High Moderate High
Dlouhy 2012 Moderate Moderate Low Moderate Low Low Moderate
Gondim 2011 Moderate Low Moderate Low High Low High
Gondim 2015 Moderate Low Moderate Moderate High Moderate High
Hofstetter 2012 Moderate Low Low Low High Moderate High
Jakimovski 2014 Moderate Moderate Moderate Moderate High Moderate High
Jang 2016 Moderate Low Moderate Low Moderate Moderate High
Karnezis 2016 Low Moderate Moderate Moderate Moderate Low High
Leach 2010 Moderate Low Moderate Moderate High Moderate High
Qureshi 2016 Moderate Moderate Moderate Moderate Moderate Moderate High
Senior 2008 Low Moderate Moderate Low High Moderate High
Sigounas 2008 Moderate Moderate Moderate Low Low Low Moderate
Thawani 2017 Moderate Moderate Moderate Moderate Moderate Moderate High
Zhan 2015 Moderate Moderate Moderate Moderate High Moderate High
Zhang 2014 Moderate Moderate Moderate Moderate Moderate Low High
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Table 3  Described risk factor per complication
Significant associations are given in bold
*Prognostic factor has a higher change of outcome
+ Positive effect; indicating a significant higher risk
− Negative effect; indicating a significant lower risk










Transient DI Permanent DI Overall DI
Demographics
 Age +30,31 =25,33,27, −20,20,24,34 =27 =27 =16 =27 =27 =27,33




 Peptic ulcer disease +34
 Various comorbidities =34
Volumetric parameters
 Tumor size =22, +17,31 =18,25,33, +25 +16 =26,29,29,29
+29
=25,26,33
 Tumor volume +17 =18,24,36 =29
 Intraventricular exten-
sion
+20 +20,21,34 +20 +20




 Extension into the ACF +20 +20
 Cavernous sinus invasion =28 =28,33
Pathology





 Cushing’s disease =24 =26
 Prolactinoma =26
 RCC +25 +26 +25,26
 Craniopharyngioma +34 =26
Surgical factors
 Previous radiation +20 =20,33, +34 +20
 Previous surgery =24,33,34 =26,26 =25,26,26
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Demographics
Age was assessed in two studies. Both studies found an 
increased risk for older age (35,36). Age was defined as a 
categorical parameter: (1) age ≥70 versus <60 years (32.7 
vs. 10%, p < 0.05) [30] and (2) age ≥50 years versus <50 
OR 2.75 (95% CI 1.18–4.32, multivariate) [31]. This shows 
an increased risk for higher age. Female gender was investi-
gated in one study, however no significant effect was found 
[31].
Tumor characteristics
Size and volume (3 studies) Tumor size and volume were 
significantly associated with increased complications in 
general in two out of three studies. Definitions used were 
(1) macroadenoma versus microadenoma OR 3.98 (2.16–
5.79, multivariate) [31], (2) tumor volume >10 cm3 versus 
<10 cm3 OR 6.3 (1.6–25.0) [17], (3) tumor diameter >3 cm 
versus <3  cm OR 4.8 (1.2–18.6) [17], and (4) maximum 
tumor diameter (no significant effect) [22].
Tumor extension (4 studies) Four out of six investigated 
risk factors showed increased risks for complications in gen-
eral. Tumor extension was defined in five different ways: (1) 
intraventricular extension, (2) Knosp grade, (3) supra-/para-
sellar extension, (4) extension into the anterior cranial fossa 
(ACF), and (5) cavernous sinus invasion. Intraventricular 
extension OR 7.85 (2.88–21.43) [20], supra-/parasellar 
extension (29.9 vs. 7.5%, p = 0.002) [31], and extension into 
the ACF OR 1.92 (1.03–3.6) [20] were significantly associ-
ated with an increased risk in one study per risk factor.
Tumor type (1 study) Tumor type was investigated in one 
study; however, no significant effect was detected [31].
Surgical factors
Previous radiation was associated with an increased risk in 
one study (OR 8.86, 95% CI 2.05–38.28) [20]. The surgeon’s 
learning curve was not associated with an increased risk of 
complications in general in two studies [19, 35].
CSF leak
Fourteen studies investigated the potential risk factors for 
postoperative CSF leaks [18–21, 23–25, 27, 28, 32–34, 
36, 37]. Postoperative incidence rates of CSF leaks varied 
between 1.4 and 16.9%. Definitions varied between clinical 
evidence of CSF rhinorrhea to no definition given. Described 
risk factors include demographics such as age, gender, BMI 
and comorbidity as well as pathology, several volumetric 
parameters, and surgical factors.
Demographics
Age (6 studies) Younger age was inconsistently associated 
with a higher risk of CSF leaks. Three studies, including 
two with overlapping cohorts [20, 34], found a significant 
association for younger age in a multivariable analysis 
with different definitions: (1) continuous: OR 0.93 (95% CI 
0.88–0.98) [24] and OR 0.98 (0.97–1.00) [34], (2) categori-
cal <40 versus >65 years OR 5.3 (1.17–24.11) [20], and (3) 
40–64 versus >65 years OR 7.9 (1.88–33.4) [20]. Covari-
ates included were: BMI and intraoperative CSF leaks.
Gender (5 studies) In two of five studies, female gender 
was associated [20, 24, 25, 33, 34] with a significant increase 
in postoperative CSF leaks [20, 34], OR 2.4 (1.24–4.63) 
[20] and p = 0.045 [34]. These two large studies (n = 982; 
1162) had overlapping cohorts.
Body mass index (BMI) (4 studies) As expected, three out 
of four studies found a significant increase in postoperative 
CSF leaks in patients with a higher BMI [20, 24, 25, 34]. 
Various definitions were used: (1) continuous, multivariate: 
OR 1.61 (1.10–2.29) [24] and OR 1.06 (1.01–1.06) [34], 
and (2) categorical: <30 versus ≥30 OR 2.10 (1.14–3.86) 
[20]. Covariates included were age [24] and intraoperative 
CSF leakage [24], and craniopharyngiomas [34]. However, 
again, two of these studies had a large overlap in included 
patients [20, 34].
Miscellaneous (1 study) One study evaluated vari-
ous comorbidities in relation to CSF leaks (Table  3) and 
found a significant association only for peptic ulcer disease 
(p = 0.029) [34].
Tumor characteristics
Tumor size or  volume (5 studies) Only one out of five 
studies looking at tumor size or volume found a significant 
association with CSF leaks [18, 24, 25, 33, 36]. These five 
studies, used various cut-off values ranging from below or 
above 10 mm to a continuous parameter of size. The only 
significant association was found for tumors larger than 
10  mm, compared to the smaller group, suggesting that 
indeed microadenoma have a lower risk for CSF leaks (34 
vs. 17%, p = 0.04) [25].
Tumor extension (7 studies) Tumor extension was ana-
lyzed in seven studies [20, 21, 28, 33, 34, 36, 37], however, 
again, defined in four different ways: (1) intraventricular 
extension [20, 21, 34], (2) supra-/parasellar extension [37], 
(3) Knosp grade [36], and (4) cavernous sinus invasion [28, 
33]. Intraventricular extension was investigated by three 
studies: (1) 8.9 versus 27.8% [21], (2) OR 9.49 (2.97–30.26) 
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[20], and (3) OR 3.58 (1.70–7.59) [34]. Presence of supra-/
parasellar extension was investigated by one study OR 8.08, 
p = 0.02 [37]. Knosp grade and cavernous sinus invasion 
were investigated by three studies; however, none of the 
studies found a significantly increased risk for postoperative 
CSF leaks [28, 33, 36]. In summary, intraventricular exten-
sion is a clear adverse factor, while supra-/parasellar exten-
sion is only confirmed in one study.
Pathology (4 studies) Four studies looked at the relation-
ship between various forms of pathology and CSF leaks [18, 
24, 25, 34]. Three studies looked at associations of individual 
tumor types, namely for Cushing’s disease [24], craniophar-
yngioma [34] and RCC [25]. RCC OR 2.6 (p < 0.001) [25], 
craniopharyngioma versus adenoma patients (p < 0.001) 
[34] and Cushing’s disease, no association [24]. Inconsist-
ent results were found for two studies looking at tumor type 
in general as a predictor for postoperative CSF leaks. As 
expected, cystic lesions, i.e. craniopharyngioma and RCC, 
appear to harbor the highest risks; however, they were only 
described once per risk factor.
Surgical factors
Previous surgery (3 studies) Previous surgery was not 
reported as a risk factor for CSF leaks [24, 33, 34].
Radiation (3 studies) Even though the frequency of sur-
gical resection after radiotherapy is low, one study found 
an increased risk for patients with prior radiotherapy; 4/14 
patients had a postoperative CSF leak [34]. The other two 
studies did not find an association [20, 33].
Learning curve (4 studies) One out of four studies con-
sidering the surgeon’s learning curve found a significant 
increase in postoperative CSF leaks [18, 19, 23, 32]. Differ-
ent cut off values were used in all four: (1) early (27 cases), 
middle (26 cases) and late (26 cases): no significant effect 
[19], (2) case 1–40 versus 41–80: no significant effect [23], 
(3) case 1–50 versus 51–203: 10 versus 0.7% (p = 0.004) 
[18], and (4) case 1–9 versus 10–78: no significant effect 
[32]. In summary, learning curve is an inconsistent risk 
factor, which only showed an effect after >50 cases in one 
study.
Intracranial infections
Two out of three studies reporting associations found a sig-
nificant association for intracranial infections [20, 27, 38]. 
Intracranial infections had an incidence rate of 0–9.8%. 
Definitions varied from no definitions to symptomatology 
in combination with positive CSF cultures. Assessed risk 
factors were: (1) age (no significant effect) [27], (2) diabe-
tes mellitus: OR 5.47 (1.09–6.49) [38] and intraventricular 
extension: OR 11.91 (3.64–38.95) [20]. Included covariates 
for diabetes mellitus were increased duration of surgery and 
CSF leakage.
Bleeding
Only two studies looked at risk factors for bleedings: (1) 
ICA injury [20], and (2) postoperative intracranial bleeds 
(hemorrhages) [20, 27]. Incidence rates for bleedings ranged 
between 0 and 4.8%. Risk factors for ICA injury included 
prior radiation OR 44.00 (3.73–519.00) and intraventricular 
extension OR 13.2 (1.35–128.91) [20]. Extension into the 
ACF OR 4.41 (2.04–9.51) was a risk factor for intracranial 
bleeds [20]. One study looked at age but did not find a sig-
nificant association for intracranial bleeds [27].
Diabetes insipidus (DI)
Eight studies looked at risk factors for DI [19, 23, 25–27, 
29, 32, 33]; incidence rates of DI ranged between 0.9 and 
36.1%. Various definitions were used: (1) transient DI, (2) 
permanent DI, and (3) overall DI.
Demographics
Age (2 studies) [27, 33], gender (2 studies) [25, 33] and race 
(1 study) [26] were not associated with a significant increase 
of DI (all three definitions).
Tumor characteristics
Tumor size or volume (4 studies) One study reported an 
association with permanent or overall DI [25, 26, 29, 33]. 
Various definitions were used: (1) transverse length >4 cm 
(no percentage given, p = 0.02) [29], (2) cranio-caudal length 
(no significant effect) [29], (3) antero-posterior length (no 
significant effect) [29], (4) maximum cross-sectional length 
(no significant effect) [29], (5) tumor volume >10 cm3 (no 
significant effect) [29], (6) continuous (no significant effect) 
[25, 33], and (7) micro- versus macroadenoma (no signifi-
cant effect) [26].
Tumor extension (1 study) Knosp grade was not associated 
with a significant increase of DI [29].
Pathology (2 studies) In overlapping cohorts, RCC was 
significantly associated with an increased risk of DI com-
pared to other tumor types: (1) 47.6 versus 20.2% (p < 0.05) 
[25], and (2) 50 versus 12%, p < 0.05 [26]. Other patholo-
gies were not associated with DI.
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Surgical factors
Previous surgery (3 studies) Previous surgery was defined 
as (1) prior non-endoscopic surgery [26], (2) prior endo-
scopic surgery [26], and (3) prior surgery [25]. None of 
them was associated with an increased risk.
Learning curve (3 studies) Learning curve was assessed 
in three studies, but not associated with an increased risk of 
DI [19, 23, 32].
Adrenal insufficiency
One out of three studies looking at adrenal insufficiency 
addressed potential associations [16]. Incidence rates ranged 
between 2.0 and 51.4%. Definitions varied between exten-
sive descriptions of used tests, while others only reported an 
insufficiency. Significant associations were found for tumor 
size, preoperative T4, IGF-1, FSH, LH and urinary-free cor-
tisol. Corrected for tumor type, patients with larger tumors 
had an increased risk of adrenal insufficiency (OR 1.07, 95% 
CI 1.01–1.13). No association was found for gender, age, 
tumor type, prolactin, TSH, testosterone, and cortisol.
Other complications of interest
Three complications were only analyzed once: cranial 
nerve injury, vision loss and sinusitis. One study found a 
significant relationship between patients with a history of an 
extrasellar tumor and cranial nerve injury (OR 5.94, 95% CI 
1.26–28.06) [20]. One study looked at older age and vision 
loss [27], while one study looked at learning curve and post-
operative sinusitis [32]; both, however, did not find a signifi-
cant association [27, 32]. Within the endoscopic literature, 
no risk factors for SIADH or mortality were found.
Table 4  Summary of preoperative risk factors for postoperative complications
Risk ratios can be found in supplementary table 2 (online supplement)
= Neutral; relation studied, however no significant increased/decreased risk found
Complications in 
general














= = = =
 Gender = Increased in 
females
= =
 BMI Higher BMI or 
>30 kg/m2





 Large or giant 
tumors
Increased in larger 
tumors
Increased in larger 
tumors
= = Increased in larger 
tumors
Increased >1 cm













 Tumor type = Increased in RCC/
craniopharyn-
gioma
= Increased in RCC
 Previous radiation Increased risk Increased risk Increased risk
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Discussion
This systematic review on preoperative risk factors for 
postoperative complications in ETS identified only two 
consistent risk factors: older age for complications in 
general and intraventricular extension for CSF leakage. 
Clear and uniform definitions of postoperative compli-
cations were mostly missing and almost all studies were 
retrospective. This resulted in a lack of standard reporting 
of complications, causing a large variation between stud-
ies regarding reported risk factors and incidence rates of 
complications.
The most frequently studied complication, CSF leaks, 
was consistently associated with intraventricular extension. 
Other risk factors were not consistent, but did not report con-
flicting results. At this stage, we conclude that intraventricu-
lar extension increases the risk of CSF leaks and lower age, 
female gender, and high BMI potentially increase the risk 
(Table 4). The second most studied association was compli-
cations in general, for which we conclude that patients with 
older age (cut off ≥50–70 years) have an increased risk of 
complications in general. Although tumor size, volume and 
extension showed inconsistent results, results indicate an 
increased risk for larger tumors and tumors with an invasive 
growth pattern. The third most studied complication was DI. 
Although found in overlapping cohorts, a significant asso-
ciation was found between RCC and DI. Results reported 
between DI and tumor size were inconsistent but were not 
conflicting. Therefore, increased tumor size/volume might 
increase the risk of DI. This should, however, be further 
investigated. For several other complications, i.e. intracra-
nial infections, serious bleedings and adrenal insufficiency, 
described associations have only been reported once. Further 
confirmation of whether these risk factors indeed increase 
the risk of complications is needed.
A distinction can be made between amendable and 
non-amendable risk factors. Even though often difficult to 
change, these should be taken into consideration in cases 
with increased risks. The learning curve is perhaps one 
of the easiest to amend. Experience (learning curve), for 
instance, appears to be an important risk factor for a lower 
risk of CSF leaks. This was confirmed in some but not all 
studies, while learning curve was not associated with any 
other complication. Obviously, learning curve statistics can 
be biased since a more experienced surgeon will operate on 
a more complex case mix with an innate higher risk of CSF 
leaks, which cannot be extracted from the currently avail-
able series. In a national survey, Ciric found that for most 
complications, surgical learning curve is an important factor 
[39]. This was assessed in 1997, however, when ETS was not 
commonplace. Based on the available literature, we advise 
taking the learning curve into account and consider referral 
to a center of excellence in cases that harbor an increased 
risk for CSF leak in itself, e.g. patients with intraventricular 
extension, lower age, females and in patients with obesity.
Increased BMI and younger age were risk factors for 
postoperative CSF leaks. This might be explained by the 
increased intra-abdominal pressure [40]. Perhaps when 
time permits, one should motivate patients to lose weight 
to reduce risks of CSF leaks postoperatively. While age 
increases in the course of time, older age is also a risk fac-
tor for complications in general. One should therefore weigh 
the risks.
Since generally only large tumors have suprasellar, intra-
ventricular extension or extension into the ACF, these risk 
factors can be considered correlated and classified under 
tumor size. When taking this into account, large or giant 
pituitary tumors are associated with complications in gen-
eral and postoperative CSF leaks. Literature on endoscopic 
resection of giant adenoma is scarce, however increased 
risk of complications can be found [41]. In particular, intra-
tumoral bleeding rates or postoperative apoplexy in tumor 
residual have been reported, ranging from 2.1 to 3.7% [6, 
42, 43]. One could argue that in firm tumors, a combined 
endoscopic transsphenoidal and open transcranial approach 
is safest for giant adenomas to maximize tumor resection 
[43–45]. Even though tumor size is often not amendable, 
in select cases one might consider medication to decrease 
tumor size, making it manageable for surgery and subse-
quently potentially lower the risk of complications, although 
this strategy is not evidence-based. However, the downside 
of medication is that it could change the tumor character-
istics, making resection less manageable. Whether tumor 
shrinkage due to medication improves complication risks 
is not assessed.
Pathology, also a non-amendable risk factor, might also 
be an important risk factor for postoperative complications. 
In particular, several associations were described for RCCs 
and craniopharyngiomas; however, only those for DI have 
been reported more than once (in overlapping cohorts). 
These two tumors have an increased risk of DI, possibly also 
for postoperative CSF leaks. The relationship with pathol-
ogy can likely be explained by the tumor etiology. Whereas 
RCCs are typically located between the anterior and poste-
rior lobe, compression/manipulation of the posterior lobe 
is likely to occur prior to or during surgery. Craniophar-
yngiomas commonly arise in the pituitary stalk, which is 
vulnerable to surgical manipulation; therefore, surgery is 
more likely to cause DI. Another risk factor found for RCCs 
was postoperative CSF leaks.
Despite being addressed only in one study, previous radia-
tion showed an association between complications in general 
and carotid artery injury. Even though radiotherapy prior to 
surgery is not common, some adenomas are very therapy 
resistant and need additional surgery. Boling et al. presented 
data from nine patients who had received radiotherapy prior 
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to surgery, showing a complication rate of 33% [20]. This 
might be explained by induced fibrosis, atrophy and vascular 
damage [46], changing the tissue structure and character-
istics, making it more fragile. While presenting results of 
microscopic surgery, Laws also described an increased risk 
of vascular injury due to radiation therapy [47].
Comparison with other systematic reviews
One of the most reviewed subjects in pituitary surgery lit-
erature is the comparison between endoscopic and micro-
scopic surgery. We found several reviews assessing the 
topic. Because the influence of surgical technique was the 
primary interest of comparison, patient-related risk factors 
were not investigated in these reviews. Typically, gross-total 
resection and complications have been compared between 
microscopy and endoscopy, most showing equal or supe-
rior results in favor of endoscopy; however, patient-related 
risk factors have not been further determined [1–10]. In the 
undivided (microscopic and endoscopic combined) litera-
ture, the following preoperative risk factors were found for 
delayed symptomatic hyponatremia by Cote [13]: higher 
age, female gender, larger tumor size, and Cushing disease. 
In the present review of endoscopic literature, no associa-
tions for delayed hyponatremia, or SIADH, and preopera-
tive risk factors were found, indicating that these are either 
not relevant for endoscopic resections, or not yet adequately 
studied.
Limitations and future perspectives
The main purpose of the study was to improve preoperative 
patient counseling and to identify high- and low-risk patients. 
The low quality of the studies precludes firm conclusions 
based on this review. Overall, most studies were retrospective 
and too small to allow multivariable analyses. Also, no meta-
analysis could be performed because of the heterogeneity 
and low number of associations. Complications were often 
defined differently and mostly gave limited descriptions. 
This complicates generalizability, and future researchers 
should aim at clearly defining (presented) complications in 
an effort to improve the clinical impact of future research on 
daily practice. Furthermore, reporting of outcomes, not only 
by centers of excellence, and prospective registration will 
lead to further evolvement in the field. Many examples, like 
the Value Based Healthcare concept [48], have shown that 
improvement in reporting of outcomes and better registration 
lead to improvements in patient-relevant outcomes.
We realize that only a subset of the total number of stud-
ies reporting on complication rates in ETS could be included 
in this study since the vast majority did not perform risk 
factor analysis. Furthermore, studies that presented only 
pooled data between microscopic and endoscopic surgery 
did not give a utilizable overview of potential risk factors for 
complications specific for patients treated through an endo-
scopic transsphenoidal approach, as in many daily practices 
nowadays.
Although many studies assessed individual risk factors of 
different types of postoperative complications, there were no 
prognostic models found in the current literature. Prognostic 
models in other fields have shown added value in individual-
ized decision-making and patient counseling. Such a model 
could have different types of outcomes, based on the aim of the 
model: complications in general, prediction of potential candi-
dates for short stay. Before implementation of such a model, it 
should be thoroughly internally and externally validated.
Although on average the reported mortality rate is around 
0.6%, unfortunately no associations were found in the cur-
rent literature. Even though incidence rates are low, they are 
not negligible. Suggested improvements for definitions and 
registration of complications might give us a better under-
standing of the etiology of these complications.
Conclusion
We present an overview of preoperative risk factors for 
postoperative complications. Only two risk factors were 
consistently associated with increased risks: older age for 
complications in general and intraventricular extension for 
CSF leakage. This does not mean that there are no other 
important risk factors, and further emphasizes the need for 
uniform definitions, reporting of outcomes and prospective 
registration. The low methodological quality of included 
studies, inconsistent results, and lack of uniform definitions 
make firm conclusions difficult. Nevertheless, we believe 
that awareness of presented risks may benefit patient coun-
seling and surgical case selection.
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